Back
Instil Bio Vs. Zevra Therapeutics Industry Stock Comparison
Buy
57
TIL
Instil Bio
Last Price:
66.11
Seasonality Move:
-42.3%
Sell
48
ZVRA
Zevra Therapeutics
Last Price:
7.84
Seasonality Move:
-17.07%
Buy
57
Instil Bio (TIL)
is a Buy
Is Instil Bio a Buy, Sell or Hold?
- The current Instil Bio [TIL] share price is $64.79. The Score for TIL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- TIL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics a Buy, Sell or Hold?
- The current Zevra Therapeutics [ZVRA] share price is $7.53. The Score for ZVRA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ZVRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TIL Stock Price Chart
What is Instil Bio's stock price today?
-
The Instil Bio share price today is $64.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TIL is experiencing slight selling pressure.
ZVRA Stock Price Chart
What is Zevra Therapeutics's stock price today?
-
The Zevra Therapeutics share price today is $7.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight buying pressure.
TIL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.79 | Buy |
| Relative Strength Index (14 RSI): | 74.81 | Buy |
| Chaikin Money Flow: | 737537 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ZVRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 56.12 | Buy |
| Chaikin Money Flow: | -565862 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
TIL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.8 | Buy |
| 20-day SMA: | 25.4 | Buy |
| 50-day SMA: | 17.16 | Buy |
| 200-day SMA: | 12.01 | Buy |
| 8-day EMA: | 49.13 | Buy |
| 20-day EMA: | 32.41 | Buy |
| 50-day EMA: | 21.22 | Buy |
| 200-day EMA: | 14.98 | Buy |
ZVRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.49 | Buy |
| 20-day SMA: | 7.39 | Buy |
| 50-day SMA: | 6.87 | Buy |
| 200-day SMA: | 5.73 | Buy |
| 8-day EMA: | 7.54 | Sell |
| 20-day EMA: | 7.35 | Buy |
| 50-day EMA: | 6.82 | Buy |
| 200-day EMA: | 5.83 | Buy |
Instil Bio Earnings Growth & TIL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.81 per share, an increase this year of $13.13 per share, and a decrease next year of $2.79 per share.
Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.29 per share, a decrease this year of $0.35 per share, and an increase next year of $1.14 per share.
Instil Bio Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zevra Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||